... (Nasdaq: SGMO) announced today the presentation of clinical data from its program to develop a ZFP TherapeuticA for HIV/AIDS. The data demonstrate a reduction in the HIV DNA reservoir since receiving SB-728-T in seven of nine HIV-infected subjects ...
http://www.sys-con.com/node/2860592
http://www.sys-con.com/node/2860592
No comments:
Post a Comment